Nu Holdings stock jumps 5% to near $18 — what’s driving NU and what investors watch next

Nu Holdings stock jumps 5% to near $18 — what’s driving NU and what investors watch next

New York, Jan 5, 2026, 21:21 EST — Market closed

Nu Holdings Ltd (NU.N), the parent of Brazilian digital lender Nubank, gained 5.4% on Monday to about $17.94 after trading between $17.02 and $18.14. Volume topped 74 million shares.

The move matters now because NU is pushing into the $18 handle just as investors start to price in the first wave of quarterly results and recalibrate risk after a strong 2025 run for equities.

It also leaves the stock closer to where many analysts peg fair value, raising the bar for the next catalyst to keep the rally intact.

Financial stocks set the tone on Wall Street, with the sector leading broader gains. “The mood has been favoring financial stocks in recent days,” said Steve Sosnick, chief market analyst at Interactive Brokers. 1

Brazil-linked lenders rose alongside Nu, with Itaú Unibanco (ITUB.N) up about 2% and Banco Bradesco (BBD.N) up roughly 4.8% in U.S. trading.

In its most recent results, Nu reported third-quarter net income of $783 million, up 39% on a currency-neutral basis — stripping out exchange-rate swings — and posted a record 31% return on equity, a measure of profit per dollar of shareholder capital, Reuters reported in November. 2

Regulation has stayed on the radar. Nubank said in December it intends to obtain a banking license in Brazil in 2026 by adding a banking institution to its conglomerate, while keeping its brand and visual identity unchanged.

Analysts tracked by MarketBeat have an average 12-month price target of $18.04 for NU, with estimates ranging from $16 to $21. 3

MarketBeat lists Nu’s next earnings date as an estimate for Feb. 19, after market close, and notes the company has not confirmed the timing.

But the run leaves Nu exposed if risk appetite fades or if credit losses rise in its consumer loan book, especially in a higher-rate or weaker-growth environment across its core markets.

For Tuesday’s session, traders will watch whether NU can hold above the $18 area, with support around $17. Macro focus turns to the U.S. Employment Situation report for December, due Friday at 8:30 a.m. ET.

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV
Previous Story

AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV

Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight
Next Story

Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

Go toTop